Literature DB >> 3534107

Experimental proctitis due to rectal infection with Chlamydia trachomatis in nonhuman primates.

T C Quinn, H R Taylor, J Schachter.   

Abstract

To serially examine the immunopathogenesis and histopathology of rectal infection with Chlamydia trachomatis, we inoculated five cynomolgus monkeys with C. trachomatis serovar E (non-LGV) and five with serovar L2 (LGV). After inoculation, C. trachomatis was isolated from rectal cultures in three of five non-LGV-infected monkeys and in all five LGV-infected monkeys for a period of 10 weeks. LGV-infected monkeys developed a severe hemorrhagic ulcerative proctitis, in contrast to a mild proctitis in the non-LGV-infected monkeys. Hyperplasia of lymphoid follicles and a mucosal polymorphonuclear leukocyte and mononuclear cell infiltrate were evident in all infected monkeys. Crypt abscesses with giant cells and a rare granuloma formation were present in two of five LGV-infected monkeys. C. trachomatis inclusions were initially present in epithelial cells and later in tissue histiocytes. Experimental primate infection with C. trachomatis appears to clinically and histopathologically mimic rectal infection in humans and provides a model for immunopathogenesis studies in chlamydial proctitis and granulomatous proctitis.

Entities:  

Mesh:

Year:  1986        PMID: 3534107     DOI: 10.1093/infdis/154.5.833

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Experimental infection with Chlamydia pneumoniae in nonhuman primates.

Authors:  S M Holland; H R Taylor; C A Gaydos; E W Kappus; T C Quinn
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  A Macaque Model for Rectal Lymphogranuloma Venereum and Non-Lymphogranuloma Venereum Chlamydia trachomatis: Impact on Rectal Simian/Human Immunodeficiency Virus Acquisition.

Authors:  Sundaram Ajay Vishwanathan; Rachael D Aubert; Monica R Morris; Chunxia Zhao; Christi Philips; George M Khalil; Frank Deyounks; Kristen Kelley; Jana M Ritter; C Y Chen; Ellen N Kersh; Janet M McNicholl
Journal:  Sex Transm Dis       Date:  2017-09       Impact factor: 2.830

3.  Oral administration of cyclosporin does not prevent expansion of antigen-specific, gut-associated, and spleen lymphocyte populations during Chlamydia trachomatis proctitis in nonhuman primates.

Authors:  M Zeitz; T C Quinn; A S Graeff; R Schwarting; S P James
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

Review 4.  Crohn's disease. New concepts of pathogenesis and current approaches to treatment.

Authors:  S P James; W Strober; T C Quinn; S H Danovitch
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

5.  Cytotoxic and immunoregulatory function of intestinal lymphocytes in Chlamydia trachomatis proctitis of nonhuman primates.

Authors:  S P James; A S Graeff; M Zeitz; E Kappus; T C Quinn
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

6.  Severity of salpingitis in mice after primary and repeated inoculation with a human strain of Chlamydia trachomatis.

Authors:  M Tuffrey; F Alexander; D Taylor-Robinson
Journal:  J Exp Pathol (Oxford)       Date:  1990-06

7.  ELISA Serology for Antibodies Against Chlamydia trachomatis in Crohn's Disease.

Authors:  Herbert J Van Kruiningen; Zeinab Helal; Ariane Leroyer; Antonio Garmendia; Corrine Gower-Rousseau
Journal:  Gastroenterology Res       Date:  2018-01-03

8.  Chlamydia trachomatis and inflammatory bowel disease--a coincidence?

Authors:  R Orda; Z Samra; Y Levy; Y Shperber; E Scapa
Journal:  J R Soc Med       Date:  1990-01       Impact factor: 18.000

Review 9.  Macaque models of human infectious disease.

Authors:  Murray B Gardner; Paul A Luciw
Journal:  ILAR J       Date:  2008

10.  A Genital Infection-Attenuated Chlamydia muridarum Mutant Infects the Gastrointestinal Tract and Protects against Genital Tract Challenge.

Authors:  Sandra G Morrison; Amanda M Giebel; Evelyn Toh; Arkaprabha Banerjee; David E Nelson; Richard P Morrison
Journal:  mBio       Date:  2020-11-03       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.